Professor, Chungbuk National University, South Korea
Profile
Scopus
Short Bio 🧬
Professor (James) Yun-Bae Kim, D.V.M., Ph.D., is a prominent expert in toxicology and neurodegenerative diseases. He serves as a professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University in Korea. He is also the CEO of Designed Cells Co., Ltd. With a distinguished career in academia and industry, Dr. Kim has contributed significantly to research on brain aging and stem cell therapies, particularly focusing on treatments for degenerative diseases such as Alzheimer’s and Parkinson’s. He has authored over 370 research papers and patents, and his work extends globally with leadership roles in China and Europe.
Education 🎓
Dr. Yun-Bae Kim completed his undergraduate studies at Seoul National University, earning his B.S. in Veterinary Medicine (1982–1985) and later his Doctor of Veterinary Medicine (DVM) certification in 1986. He pursued further graduate studies at the same institution, completing an M.S. (1986–1987) and a Ph.D. in Toxicology (1994–1996), specializing in the toxicopathologic mechanisms of alkylating vesicants and therapies for their poisonings. His education laid a solid foundation for his career in toxicology and neurodegenerative disease research.
Experience 💼
Dr. Kim began his career as a researcher at Korea’s Agency for Defense Development (ADD) from 1988 to 2002, where he eventually rose to the rank of senior researcher. Since 2002, he has been a professor at Chungbuk National University, mentoring students and leading cutting-edge research in toxicology. His professional engagements also include visiting professorships at the University of British Columbia and Qingdao Agricultural University, along with executive roles such as CEO of Designed Cells Co., Ltd., and leadership positions in stem cell therapy companies across Korea, China, and Croatia.
Research Interests 🔬
Dr. Kim’s research focuses primarily on neurotoxicopathology and neurodegenerative diseases. His recent work involves the development of stem cells encoding functional genes for treating conditions like Alzheimer’s disease, stroke, multiple sclerosis, and Lou Gehrig’s disease. His pioneering studies on neural stem cells, which show effectiveness against Alzheimer’s dementia, have earned international recognition. Additionally, he explores therapeutic applications for aging and chronic inflammatory diseases such as glaucoma and arthritis.
Awards 🏆
Throughout his career, Dr. Kim has earned several accolades for his contributions to science and research. Notably, he has been recognized by the Marquis Who’s Who (28th edition, 2012), the 21st Century Korean Roll (2007), and numerous editorial roles on prominent journals such as the Journal of Ginseng Research and Molecules. His ongoing commitment to advancing medical and veterinary science through both research and innovation continues to garner global attention.
Publications Top Notes 📚
Dr. Kim has published extensively on various aspects of toxicology, neurodegeneration, and stem cell research. Here are some of his key publications:
Lee, Y.-S., Kim, Y.-B., Ahn, B.-O., et al. (1987). Teratological study of recombinant human interferon-αA in rats. Korean J. Toxicol, 3, 45-53. [Cited by: 3 articles]
Lee, Y.-S., Kim, Y.-B., Kim, H.-S., et al. (1987). Peri-natal and postnatal study of recombinant human interferon-αA in rats. Korean J. Toxicol, 3, 55-63. [Cited by: 2 articles]
Lee, Y.-S., Kim, Y.-B., Ahn, B.-O., et al. (1987). Teratogenic study of recombinant human interferon-αA in rabbits. Korean J. Toxicol, 3, 65-72. [Cited by: 4 articles]
Lee, Y.-S., Park, J.-H., Kim, Y.-B., et al. (1988). Local irritation test of gamma human interferon. Korean J. Lab. Anim. Sci, 4, 47-55. [Cited by: 1 article]
Kim, Y.-B., Lee, Y.-S. (1988). Inhibitory effects of red ginseng extract on preneoplastic nodule formation in rat liver. Korean J. Toxicol, 4, 159-179. [Cited by: 6 articles]